A clinical research team from the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), and international genetic researchers led a global research study using multi-omics analysis and ...

Rett syndrome is a rare genetic disease affecting 1 in 10,000 newborn girls, characterized by sudden regression around 1 year ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

ZERO Prostate Cancer (ZERO), the nation's leading advocacy and support foundation for prostate cancer awareness, has announced the launch of Blitz the Barriers during Cancer Prevention Month. This ...

Cronometer, a leader in nutrition and health tracking, is proud to announce the integration of Continuous Glucose Monitors (CGMs) with its innovative platform. This feature provides users with the ...

Australia's Minister for Health and Aged Care, Mark Butler, has commented on medical cannabis and the Pharmaceutical Benefits ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Presently, there are approximately two-dozen distinct molecular entities marketed worldwide for the treatment of epilepsy. With only a few exceptions, these drugs were discovered by screening in ...

for treating Dravet syndrome. Following discussions with the FDA, the European Medicines Agency and Japan’s Pharmaceuticals and Medical Devices Agency, Stoke Therapeutics decided on the protocol ...

Stoke Therapeutics (STOK) was a big mover last session on higher-than-average trading volume. The latest trend in earnings ...

other (see Budson and Solomon8 for complete list and description of the various disorders) History and testing may be consistent with various clinical phenotypes CT and MRI may show vascular ...